Podcast Episodes

Back to Search
Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Jemperli
Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Jemperli

METiS TechBio and Eli Lilly collaborate on next-generation LNP delivery technology, Incubate’s John Stanford on how MFN deals may shape future pharma…

4 weeks, 1 day ago

Short Long
View Episode
Pharmaceutical Executive Daily: Hansoh Pharma Enters Collaboration and License Agreement with Roche for Broad Portfolio of ADCs
Pharmaceutical Executive Daily: Hansoh Pharma Enters Collaboration and License Agreement with Roche for Broad Portfolio of ADCs

Merck KGaA, Darmstadt, Germany, acquires Silence Therapeutics for $1.3 billion, Hansoh Pharma and Roche expand their ADC partnership in a deal worth …

4 weeks, 2 days ago

Short Long
View Episode
Pharmaceutical Executive Daily: Gilead Enters $1.87 Billion Collaboration and License Agreement with Vir Biotechnology

Gilead and Vir Biotechnology strike a $1.87 billion T-cell engager collaboration, and Fox Rothschild’s Marc Wagner examines what slows manufacturers’…

1 month ago

Short Long
View Episode
Pharmaceutical Executive Daily: Rona Therapeutics Enters Global License Agreement for ALK7-targeting RNAi Therapy with Roche
Pharmaceutical Executive Daily: Rona Therapeutics Enters Global License Agreement for ALK7-targeting RNAi Therapy with Roche

Experts warn prediction markets are exposing gaps in pharma vendor confidentiality agreements, Roche licenses Rona Therapeutics’ obesity RNAi candida…

1 month ago

Short Long
View Episode
Pharmaceutical Executive Daily: Thomas Appio Named Interim CEO of Bausch + Lomb
Pharmaceutical Executive Daily: Thomas Appio Named Interim CEO of Bausch + Lomb

Bausch + Lomb names Thomas Appio interim CEO as Brent Saunders departs, a Pharm Exec interview explores how AI is reshaping entry-level apprenticeshi…

1 month ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Tecentriq
Pharmaceutical Executive Daily: FDA Approves Tecentriq

The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new IPOs, and a Pharmaceutical …

1 month, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: Ultragenyx Sells Rare Pediatric Disease Priority Review Voucher
Pharmaceutical Executive Daily: Ultragenyx Sells Rare Pediatric Disease Priority Review Voucher

Ultragenyx sells a rare pediatric disease priority review voucher for $210 million, Viatris acquires Pacira BioSciences for $1.65 billion, and Peter …

1 month, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Tukysa Plus Trastuzumab and Pertuzumab
Pharmaceutical Executive Daily: FDA Approves Tukysa Plus Trastuzumab and Pertuzumab

Caribou Biosciences discontinues its two allogeneic CAR-T programs, Kamal Biswas makes the case for continuous quality management maturity, and FDA a…

1 month, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: What HCP Engagement Actually Looks Like
Pharmaceutical Executive Daily: What HCP Engagement Actually Looks Like

Shionogi, Gate Bioscience, and Alector post a trio of new deals, Rajul Jain makes the case for social listening as a medical affairs strategic tool, …

1 month, 1 week ago

Short Long
View Episode
AI and Patient Recruitment: Can Predictive Promise Drive True Transformation?
AI and Patient Recruitment: Can Predictive Promise Drive True Transformation?


Can artificial intelligence help turn what many believe is clinical development’s biggest variable — and most prevailing bottleneck — into a more pr…

1 month, 1 week ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us